MX2009013019A - Modificacion de liberacion de farmaco en suspensiones de sistemas de resina ionica. - Google Patents
Modificacion de liberacion de farmaco en suspensiones de sistemas de resina ionica.Info
- Publication number
- MX2009013019A MX2009013019A MX2009013019A MX2009013019A MX2009013019A MX 2009013019 A MX2009013019 A MX 2009013019A MX 2009013019 A MX2009013019 A MX 2009013019A MX 2009013019 A MX2009013019 A MX 2009013019A MX 2009013019 A MX2009013019 A MX 2009013019A
- Authority
- MX
- Mexico
- Prior art keywords
- suspensions
- drug release
- resin systems
- ionic resin
- modifying drug
- Prior art date
Links
- 239000011347 resin Substances 0.000 title abstract 3
- 229920005989 resin Polymers 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000000725 suspension Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000012266 salt solution Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94095607P | 2007-05-30 | 2007-05-30 | |
| PCT/US2008/065408 WO2008151071A1 (en) | 2007-05-30 | 2008-05-30 | Modifying drug release in suspensions of ionic resin systems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009013019A true MX2009013019A (es) | 2010-04-01 |
Family
ID=40094143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013019A MX2009013019A (es) | 2007-05-30 | 2008-05-30 | Modificacion de liberacion de farmaco en suspensiones de sistemas de resina ionica. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8313770B2 (enExample) |
| EP (1) | EP2164631A4 (enExample) |
| JP (1) | JP2010529040A (enExample) |
| CA (1) | CA2689101C (enExample) |
| MX (1) | MX2009013019A (enExample) |
| WO (1) | WO2008151071A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2018160T3 (da) | 2006-03-16 | 2012-02-06 | Tris Pharma Inc | Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser |
| AU2008296298B2 (en) | 2007-09-06 | 2012-12-06 | The Cola-Cola Company | Systems and methods for monitoring and controlling the dispense of a plurality of product forming ingredients |
| RU2496711C2 (ru) | 2007-09-06 | 2013-10-27 | Дзе Кока-Кола Компани | Система и способ программирования вариантов дозирования в разливочном устройстве для приготовления продуктов |
| US20100273822A1 (en) * | 2009-04-22 | 2010-10-28 | William Wayne Howard | Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins |
| BR112012013487A2 (pt) | 2009-12-02 | 2017-10-03 | Adamas Pharmaceuticals Inc | Composições de amantadina e métodos de uso |
| US8470375B1 (en) | 2010-01-05 | 2013-06-25 | Neos Therapeutics, Lp | Method of formulating and designing liquid drug suspensions containing ion exchange resin particles |
| US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
| US9339478B2 (en) * | 2011-02-04 | 2016-05-17 | Reckitt Benckiser Llc | Pharmaceutical formulation |
| US8287903B2 (en) * | 2011-02-15 | 2012-10-16 | Tris Pharma Inc | Orally effective methylphenidate extended release powder and aqueous suspension product |
| EP2508174A1 (en) * | 2011-04-06 | 2012-10-10 | Ljiljana Sovic Brkicic | Pharmaceutical composition |
| US20130004586A1 (en) * | 2011-06-24 | 2013-01-03 | Vachon David J | Biologically Efficacious Compositions, Articles of Manufacture and Processes for Producing and/or Using Same |
| EP2726066B1 (en) | 2011-06-28 | 2021-03-31 | Neos Therapeutics, LP | Dosage forms of amphetamine for oral administration |
| CA2880456A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US20140122120A1 (en) * | 2012-10-30 | 2014-05-01 | Pacesetter, Inc. | Systems and methods for providing photo-based patient verification for use with implantable medical device programmers |
| CA2898408C (en) | 2013-02-28 | 2018-01-02 | Pfizer Inc. | Enhanced stability of novel liquid compositions |
| US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
| WO2016001937A2 (en) * | 2014-06-30 | 2016-01-07 | Rubicon Research Private Limited | Modified release pharmaceutical preparations |
| AU2015324986A1 (en) * | 2014-10-01 | 2017-04-20 | Crop Enhancement, Inc. | Agrochemical resinates for agricultural applications |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| JP2019515045A (ja) * | 2016-05-03 | 2019-06-06 | スペクトリックス セラピューティクス， エルエルシーＳｐｅｃｔｒｉｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｌｌｃ | 甲状腺ホルモン又はそのアナログを提供する組成物及び方法 |
| MX2020002078A (es) | 2017-08-24 | 2020-09-21 | Adamas Pharma Llc | Composiciones de amantadina, preparaciones de estas y métodos de uso. |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| WO2019074829A1 (en) * | 2017-10-09 | 2019-04-18 | Rhodes Pharmaceuticals L.P. | RESINATE-BASED PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM |
| WO2019094292A1 (en) * | 2017-11-09 | 2019-05-16 | Spectrix Therapeutics, LLC | Compositions and methods of providing thyroid hormone of analogs thereof |
| AU2018388577B2 (en) | 2017-12-18 | 2024-06-06 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release |
| WO2019126214A1 (en) | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release |
| CA3085941A1 (en) | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK79841C (da) * | 1952-08-04 | 1955-09-12 | Behringwerke Ag | Fremgangsmåde til fremstilling af stabile γ-globulinpræparater. |
| US3173876A (en) * | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
| US3276586A (en) * | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
| US3546142A (en) * | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
| US3541006A (en) * | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
| US3541005A (en) * | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
| US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
| US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
| US4762709A (en) * | 1983-09-16 | 1988-08-09 | Pennwalt Corporation | Liquid prolonged release pharmaceutical formulations containing ionic constituents |
| AU565487B2 (en) * | 1983-09-16 | 1987-09-17 | Fisons Corporation | Liquid prolonged release pharmaceutical formulations containing ionic constituents |
| US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
| US4999189A (en) * | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
| GB9005498D0 (en) * | 1990-03-12 | 1990-05-09 | Beecham Group Plc | Composition |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| SE505146C2 (sv) * | 1995-10-19 | 1997-06-30 | Biogram Ab | Partiklar för fördröjd frisättning |
| US5980945A (en) * | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| US6613358B2 (en) * | 1998-03-18 | 2003-09-02 | Theodore W. Randolph | Sustained-release composition including amorphous polymer |
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| EP1250937B1 (en) * | 2001-04-09 | 2009-05-13 | Rohm And Haas Company | Controlled dissolution of active ingredients |
| CA2509429A1 (en) * | 2002-11-26 | 2004-06-10 | University Of Maryland, Baltimore | Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| US20050232987A1 (en) * | 2004-03-12 | 2005-10-20 | Viswanathan Srinivasan | Dosage form containing a morphine derivative and another drug |
| EP1898913A1 (en) * | 2005-06-28 | 2008-03-19 | Ucb, S.A. | Multiple active drug-resin conjugate |
| US20070092553A1 (en) * | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
-
2008
- 2008-05-30 MX MX2009013019A patent/MX2009013019A/es not_active Application Discontinuation
- 2008-05-30 EP EP08769926.0A patent/EP2164631A4/en not_active Withdrawn
- 2008-05-30 WO PCT/US2008/065408 patent/WO2008151071A1/en not_active Ceased
- 2008-05-30 JP JP2010510531A patent/JP2010529040A/ja active Pending
- 2008-05-30 US US12/130,762 patent/US8313770B2/en active Active
- 2008-05-30 CA CA2689101A patent/CA2689101C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8313770B2 (en) | 2012-11-20 |
| US20090011027A1 (en) | 2009-01-08 |
| CA2689101A1 (en) | 2008-12-11 |
| WO2008151071A1 (en) | 2008-12-11 |
| EP2164631A4 (en) | 2013-08-21 |
| CA2689101C (en) | 2013-01-22 |
| JP2010529040A (ja) | 2010-08-26 |
| EP2164631A1 (en) | 2010-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009013019A (es) | Modificacion de liberacion de farmaco en suspensiones de sistemas de resina ionica. | |
| CY1122732T1 (el) | Συνθεσεις για αναπνευστικη χορηγηση δραστικων παραγοντων και συναφεις μεθοδοι και συστηματα | |
| EA201190295A1 (ru) | Композиции для дермальной доставки, содержащие комплексы активного агента с частицами фосфата кальция, и способы их применения | |
| SG10201804552WA (en) | Nanoparticle compositions, formulations thereof, and uses therefor | |
| MX2013002048A (es) | Conjugados, particulas, composiciones y metodos relacionados. | |
| WO2013006729A3 (en) | Cannabinoid receptor binding agents, compositions and methods | |
| UA122868C2 (uk) | Тетрагідропіридо[3,4-в]індолові модулятори естрогенових рецепторів та їх застосування | |
| PH12016500372A1 (en) | Pharmaceutical composition containing pyrimidine compound as active ingredient | |
| MX2013008146A (es) | Mejoras en tecnologia de revestimiento. | |
| SG182629A1 (en) | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | |
| MY161236A (en) | (pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 nachr | |
| BR112015023509A2 (pt) | uso de derivados com ligações c-o-p em pacientes com insuficiência renal | |
| MX2012001693A (es) | Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida. | |
| MX341642B (es) | Composicion de liberacion sostenida que contiene peptidos como ingredientes activos. | |
| MY166972A (en) | Transdermal delivery system containing galantamine or salts thereof | |
| EA201890703A1 (ru) | Коллоидные частицы, предназначенные для применения в медицине | |
| MX2009003815A (es) | Formulaciones farmaceuticas. | |
| EP2568990A4 (en) | METHOD OF PRODUCING PLEURODESIS | |
| MX2014014536A (es) | Nuevo sistema de liberacion de proteinas hidrofobicas. | |
| PH12013500126A1 (en) | Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile | |
| WO2022146367A3 (en) | Nanocone clusters suitable for use as histotripsy agent | |
| NZ709409A (en) | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | |
| MX367779B (es) | Método de obtención de nanoestructuras superparamagnéticas híbridas con fármaco y su uso como agente antineoplásico controlable y dirigible mediante campos magnéticos. | |
| MX2010008525A (es) | Forma farmaceutica bicapa de dicloxacilina. | |
| UA34458U (ru) | Фармацевтическая композиция, содержащая инсулин |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |